Eagle Pharmaceuticals Inc

NASDAQ:EGRX  
43.22
+1.41 (+3.37%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)563.15M
Current PE114.07
Forward PE 12.86
2yr Forward PE 10.12
See more stats
Estimates Current Quarter
Revenue$45.06 Million
Adjusted EPS$0.73
See more estimates
10-Day MA$43.53
50-Day MA$47.34
200-Day MA$46.23
See more pivots

Eagle Pharmaceuticals, Inc. Stock, NASDAQ:EGRX

50 Tice Boulevard, Suite 315, Woodcliff Lake, New Jersey 07677-9991
United States of America
Phone: +1.201.326.5300
Number of Employees: 108

Description

Eagle Pharmaceuticals, Inc. engages in the provision of injectable products. Its products include argatroban, ryanodex, docetaxel injection, non-alcohol formulation and bendeka. The company was founded by Scott L. Tarriff on January 2, 2007 and is headquartered in Woodcliff Lake, NJ.